Vera Therapeutics, Inc. Class A Common Stock

VERANASDAQ • USD
25.91 USD
↘ 1.06 (3.93%)🟢LIVE (AS OF 11:30 AM EST)
🟢Market: OPEN

Vera Therapeutics, Inc. Class A Common Stock (VERA) trades at $25.91 per share. Technicals currently rate "Strong Sell" while our fundamental analysis reads "Neutral". This is driven by a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. On the valuation front, VERA trades at elevated multiples relative to its peers, earning a "Richly Valued" assessment.

Technical & fundamental data as of Nov 16, 2026.

Open?$27.00
High?$30.53
Low?$25.88
Prev. Close?$26.97
Volume?423.1K
Avg. Volume?1.6M
VWAP?$26.21
Rel. Volume?0.26x
Bid / Ask
Bid?$25.98 × 100
Ask?$26.28 × 100
Spread?$0.30
Midpoint?$26.13
Valuation & Ratios
Market Cap?1.9B
Shares Out?72.3M
Float?63.2M
Float %?87.7%
P/E Ratio?N/A
P/B Ratio?5.85
EPS?-$5.76
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.
Employees
362
Market Cap
1.9B
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2021-05-14
Address
2000 SIERRA POINT PARKWAY, SUITE 1200
BRISBANE, CA 94005
Phone: 650-770-0077
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
85
Momentum?
50
Short Sent.?
50
Piotroski F-Score?0/9Weak
Altman Z-Score?3.55Safe
Confidence?48%Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?19.21%High
Short Interest?12.1M
Days to Cover?8.5
Free Float63.2M
Avg Daily Volume1.4M
Settlement Date2026-10-30
Financial Health
Current Ratio?7.91Strong
Quick Ratio?7.78Strong
Cash Ratio?0.99Adequate
Debt/Equity?0.23Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
58/100
P/E?
N/A▾
P/B?
Peers
100
S&P
32
5.85FAIR▾
P/S?
Peers
100
S&P
3
189.73HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-4.6CHEAP▾
EV/Sales?
Peers
100
S&P
3
191.69HIGH▾
Returns & Efficiency
ROE?
S&P
3
-125.0%WEAK▾
ROA?
S&P
3
-89.4%WEAK▾
Cash Flow & Enterprise
FCF?$-376048000
Enterprise Value?$2.0B
Fundamentals ratios updated end of day